Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs IND SWIFT LA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA IND SWIFT LA SUN PHARMA/
IND SWIFT LA
 
P/E (TTM) x 43.2 13.0 332.9% View Chart
P/BV x 6.9 0.9 815.2% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 SUN PHARMA   IND SWIFT LA
EQUITY SHARE DATA
    SUN PHARMA
Mar-23
IND SWIFT LA
Mar-23
SUN PHARMA/
IND SWIFT LA
5-Yr Chart
Click to enlarge
High Rs1,07277 1,392.1%   
Low Rs79051 1,545.5%   
Sales per share (Unadj.) Rs182.9204.3 89.5%  
Earnings per share (Unadj.) Rs35.78.1 440.8%  
Cash flow per share (Unadj.) Rs46.217.8 259.6%  
Dividends per share (Unadj.) Rs11.500-  
Avg Dividend yield %1.20-  
Book value per share (Unadj.) Rs233.4115.4 202.2%  
Shares outstanding (eoy) m2,399.3459.09 4,060.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.10.3 1,623.5%   
Avg P/E ratio x26.17.9 329.7%  
P/CF ratio (eoy) x20.13.6 559.7%  
Price / Book Value ratio x4.00.6 718.7%  
Dividend payout %32.20-   
Avg Mkt Cap Rs m2,233,3613,785 59,013.1%   
No. of employees `000NANA-   
Total wages/salary Rs m82,9601,262 6,575.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m438,85712,073 3,635.0%  
Other income Rs m8,199335 2,447.3%   
Total revenues Rs m447,05512,408 3,602.9%   
Gross profit Rs m112,9002,026 5,573.9%  
Depreciation Rs m25,294574 4,409.6%   
Interest Rs m1,720922 186.6%   
Profit before tax Rs m94,084865 10,874.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,476387 2,190.7%   
Profit after tax Rs m85,608478 17,898.1%  
Gross profit margin %25.716.8 153.3%  
Effective tax rate %9.044.7 20.1%   
Net profit margin %19.54.0 492.4%  
BALANCE SHEET DATA
Current assets Rs m398,61911,631 3,427.2%   
Current liabilities Rs m199,0643,711 5,364.3%   
Net working cap to sales %45.565.6 69.3%  
Current ratio x2.03.1 63.9%  
Inventory Days Days14710 1,409.1%  
Debtors Days Days951,528 6.2%  
Net fixed assets Rs m376,9606,297 5,986.5%   
Share capital Rs m2,399598 401.2%   
"Free" reserves Rs m557,5556,221 8,962.1%   
Net worth Rs m559,9546,819 8,211.3%   
Long term debt Rs m07,526 0.0%   
Total assets Rs m775,79417,942 4,323.9%  
Interest coverage x55.71.9 2,873.0%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.60.7 84.1%   
Return on assets %11.37.8 144.3%  
Return on equity %15.37.0 218.0%  
Return on capital %17.112.5 137.4%  
Exports to sales %073.4 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA8,859 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m154,0538,859 1,738.9%   
Fx outflow Rs m71,511285 25,096.1%   
Net fx Rs m82,5418,574 962.7%   
CASH FLOW
From Operations Rs m49,5931,946 2,548.2%  
From Investments Rs m-79,437-134 59,423.1%  
From Financial Activity Rs m23,761-1,857 -1,279.8%  
Net Cashflow Rs m1,155-44 -2,621.0%  

Share Holding

Indian Promoters % 54.5 42.0 129.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.6 19.0 192.2%  
FIIs % 17.1 0.3 5,509.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.5 58.0 78.5%  
Shareholders   612,626 24,633 2,487.0%  
Pledged promoter(s) holding % 2.4 86.8 2.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Sun Pharma vs IND SWIFT LA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Sun Pharma vs IND SWIFT LA Share Price Performance

Period Sun Pharma IND SWIFT LA S&P BSE HEALTHCARE
1-Day 0.77% 2.56% 1.18%
1-Month 3.00% -7.66% -0.75%
1-Year 64.65% 81.37% 61.82%
3-Year CAGR 39.45% 10.40% 18.16%
5-Year CAGR 27.78% 19.70% 19.79%

* Compound Annual Growth Rate

Here are more details on the Sun Pharma share price and the IND SWIFT LA share price.

Moving on to shareholding structures...

The promoters of Sun Pharma hold a 54.5% stake in the company. In case of IND SWIFT LA the stake stands at 42.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Sun Pharma and the shareholding pattern of IND SWIFT LA.

Finally, a word on dividends...

In the most recent financial year, Sun Pharma paid a dividend of Rs 11.5 per share. This amounted to a Dividend Payout ratio of 32.2%.

IND SWIFT LA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Sun Pharma, and the dividend history of IND SWIFT LA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.